🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Chemours names Alister Cowan as new board director

EditorHari Govind
Published 11/23/2023, 10:58 AM
© Reuters.
CC
-

WILMINGTON, DELAWARE - The Chemours Company (NYSE:CC), a global leader in Titanium Technologies, Advanced Performance Materials, and Thermal & Specialized Solutions, announced significant changes to its board of directors. Alister Cowan has been appointed as a director following the retirement of Curtis Crawford. This transition comes after the pre-announcement made last Friday.

Cowan's background includes his recent role as Executive Advisor at Suncor Energy (NYSE:SU) Inc. and prior positions as CFO at Suncor until 2023 and Husky Energy (OTC:HUSKF) Inc. His global finance expertise is expected to be instrumental in driving stakeholder value for Chemours. Cowan, whose academic achievements include Chartered Accountant status from Heriot-Watt University in Scotland, brings a wealth of international experience from regions such as Europe and Canada to the Chemours board.

InvestingPro Insights

The Chemours Company, amid board transitions and global financial strategy adjustments, is currently navigating through a challenging financial landscape. According to real-time data from InvestingPro, Chemours has a market capitalization of $3.89 billion and is experiencing a decline in revenue, with a -14.61% change over the last twelve months as of Q3 2023. The company's stock price is also reflecting volatility, which could be a point of concern for potential investors. Moreover, the company's Price / Book ratio stands at 5.16, indicating a relatively high valuation of the company's assets.

One of the InvestingPro Tips highlights that Chemours operates with a significant debt burden, which is a critical factor for stakeholders to consider, especially when evaluating the company's financial health and long-term sustainability. Additionally, the tip that analysts predict the company will be profitable this year offers a glimmer of hope for a turnaround in its financial performance.

For investors seeking a comprehensive analysis, InvestingPro provides further insights, including additional InvestingPro Tips that can be found at https://www.investing.com/pro/CC. Currently, there are more than 8 tips available for Chemours, offering a deeper dive into what to expect from the company in the upcoming period. With the current Black Friday sale, a subscription to InvestingPro is now even more accessible, offering up to a 55% discount, making it an opportune time for investors to gain access to valuable financial information and analytics.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.